Lupin informs about press release

04 Dec 2025 Evaluate
Lupin has informed that it enclosed a Press Release titled ‘Lupin and Valorum Enter into an Exclusive Licensing Agreement for Biosimilar Armlupeg (Pegfilgrastim-unne) in the United States.’

The above information is a part of company’s filings submitted to BSE. 

Lupin Share Price

2334.95 33.25 (1.44%)
10-Mar-2026 15:00 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1810.20
Dr. Reddys Lab 1313.20
Cipla 1336.25
Zydus Lifesciences 922.45
Lupin 2334.95
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×